Personal Information

Prof. Chandi C. Mandal

Professor, Head & Dean
Department of Biochemistry

M.Sc. (Biochemistry; Calcutta University), Ph.D. (Biotechnology; IIT-Kharagpur), Postdoctoral Training (University of Texas Health Science Center at San Antonio, Texas, USA), CPRIT Fellowship (USA-Govt.); ASBMR Young Investigator Award

ccmandal@curaj.ac.in

91

Brief overview:

Prof. Chandi C. Mandal's research aims at understanding molecular mechanisms of dysregulated gene expressions and cellular signaling networks associated with debilitating cancer diseases, by carrying out cell-based experiments, cancer tissue and database analysis. Exploring the impact of various metabolic disorders including diabetes, obesity and hypercholesterolemia, and extrinsic risk factor (cold temperature) on the peculiar trans-differentiation property of epithelial breast cancer cells into osteoblast- and adipocyte-like cells is a major focus. Non-toxic drug candidates are preferred to cease dysregulated signaling pathways via hindering the gene targets. Research of this laboratory also seeks to examine if cholesterol-lowering statins, omega-3 fatty acids and anti-diabetic metformin can be combined with other anti-cancer drugs to show better.

Dr. Mandal's academic endeavour is not only reflected in the publications of his research work, but he is also recipient of Investigator Award from ASBMR, USA and fellowship Award from CPRIT, USA.  His research work has also been highlighted multiple times in Newspaper and reported in Television channels. He is a member of several professional societies such as IACR, BRSI, ISCA.  

He is editorial board member of various journals such as associate editor of “Frontiers in Endocrinology-bone section” and “BMC Cancer”, and academic editor of “PLOS ONE”, and editorial member of "Scientific Reports [npg]" , "Journal of Biochemical and Molecular Toxicology”, "Oncology Letters" and “Current Drug Targets". He has enlisted in the  TOP 2% scientists in the world made by Stanford University in 2021, published in Plos Biology.

Area of Interest: Cellular Signaling associated with Cancer and Bone Biology.

Research Keywords: Cell biology, Cancer, Bone metastasis, Bone remodelling, Cancer calcification, Osteoblast, Osteoclast, Apoptosis, Epithelial to mesenchymal transition and Cellular signalling.

Topic edited:            (i) Cancer and bone metastasis [Edited] in "Frontiers in Endocrinology" Link: https://bit.ly/cancer-bonemetastasis-chandi

                                 (ii) Cancer and bone metastasis II [Edited] in Frontiers in Endocrinology"  Link: https://bit.ly/bonemetastasisii

                                 (iii) Bone cell differentiation in health and disease [Edited] in Frontiers in Endocrinology  Link: https://bit.ly/osteoblast-health

                                (iv) Lipids and cancer in "Current Drug Targets" [Editing] Link: https://bit.ly/lipid-cancer-chandi

Opportunity for PhD, Postdoc and project fellow: Interested candidates may send CV to ccmandal@curaj.ac.in

News on COVID-19:  

https://bit.ly/newschandiCOVID-19

https://bit.ly/Newschandicovid19-video

https://bit.ly/newschandicovid-19

Others:

Website: https://chandicmandal.webs.com

Publications: https://bit.ly/GscholarChandicmandal

Pubmed: https://bit.ly/PubMed-CCM

 

 

  Year                         Position                                            Institution/University

2019-Present                                 Professor                                  Department of Biochemistry, Central University of Rajasthan, India

2016-2019                  Associate Professor & Head                        Department of Biochemistry, Central University of Rajasthan, India

2013-2016                      Assistant Professor                                   Department of Biochemistry, Central University of Rajasthan, India

2012-2013                      Assistant Professor                                   Department of Biotechnology, Sharda University (U.P.), India

2006-2012                      Postdoctoral Fellow                                   Department of Pathology, University of Texas Health Science                                                                                                                                                                       Center at San Antonio, USA

2000-2006                      Rsearch Scholar                                        Indian Institute of Technology, Kharagpur, India

Research Interest:

Dr. Mandal's research interest is aimed at understanding the cellular signal transduction mechanisms involved in breast cancer, bone metastasis and calcification using molecular and cellular biology techniques and animal model systems. Cancer incidence risk is enormously high in all over the world but deaths related to cancer are rapidly increasing in developing countries like India. Advanced techniques are skilled to detect cancers in early stages. Moreover, modern treatment strategies are now quite efficient to extend the life span of cancer patients by taking care of primary tumors. It is the fact that almost 80% of cancer patients die mainly due to its metastatic growth in distant organs. The occurrence of metastasis incidence is also increasing due to improve results of primary tumor treatment strategy. Very limited drugs are available in prevention of metastasis-related death although success level is very small. Thus it becomes a deadly threat to cancer patients once primary tumor cells have metastasized to distant sites. Risk of cancer incidence has been linked with different diseases including diabetes, hypercholesterolemia and obesity. Moreover, treatment of cancer patients with chemotherapies, radiation therapies often show  deleterious side effects. Therefore, there is an urgent need for improved understanding of the molecular biology of these diseases and development of more selective and targeted pharmacologic therapeutics.

Dr. Mandal  focuses his research area on i) finding the molecular mechanism involved in diabetes-associated cancer risk ii) prevention of chemotherapeutic drug-induced systemic toxicity, iii) finding the molecular pathways involved in diabetes-driven  calcification.

Dr. Mandal’s newly developed interests on bone metastasis of breast cancer and signalling crosstalk of osteoblast and osteoclast during bone remodeling have been very significant insight into molecular mechanism of these diseases. 

Current objectives:

  •  Finding the underlying molecular mechanism for cholesterol-induced cancer growth and  metastasis
  •  Investigating the molecular mechanism involved in cancer microcalcification and its prevention strategy
  •  Investigating the target identification for cold-mediated tumorigenesis
  •  Study for preventing mutation in mutation prone zones in cancer genome
  • Identification of bioactive secondary metabolites for prevention of cancer metastasis

 

Link:       https://www.dailymotion.com/video/x7vgdvn

Link:     https://www.youtube.com/watch?v=LYKXPIYoX0g

Link:     https://www.youtube.com/watch?v=IZPYhHMbbU4

Link:     https://www.firstpost.com/health/covid-19-spread-may-hasten-during-winter-suggest-indian-scientists-as-study-shows-high-caseload-in-colder-regions-8574931.html

Link:    https://scholar.google.co.in/citations?user=p6uxNRcAAAAJ&hl=en

Lab Members:

Sneha Soni:                                   Ph.D. Pursuing                  Research Area: Adipocyte and Cancer

Pooja:                                             Ph.D. Pursuing                  Research Area: Epigenetics and Cancer

Manas Mahapatra:                                 Ph.D. Pursuing                   Rsearch area: Zinc finger proteins and Cancer

Sweta Makwana:                                   Ph.D. Pursuing                    Research area: Diabetes and Metastasis

Shivani Bansal:                                    Ph.D. Pursuing                    Research area: Osteoblast-like potential and Cancer

Monika Kumari :                                   Ph.D. Pusuing                      Rsearch area: Zinc finger protein and cancer

 

Former members:

Dr. Shreetama Bandyopadhayaya:   Post Doctoral Fellow, USA

Dr. Tanu Sharma:                                 Post Doctoral Fellow, USA

Suresh Kumar:                               Patent Officer (New Delhi)                                    

Kaushik Chowdhury:                        Ph.D. students (Academia Sinica, Taiwan)     

Dr. Ankit Sharma:                             Association with LabRx  Immunologic Therapeutics  Pvt Ltd., California, USA

  

 

 

S. No. Authors Title of Article Journal/Conference Details Journal/Conference Publication Year
1 2020

Publications in Peer-Reviewed Journals:

  1.  Yadav P,  Bandyopadhayaya S, Soni S, Saini S, Sharma LK, Shrivastava SK and Mandal CC*, Simvastatin prevents BMP-2 driven cell migration and invasion by suppressing oncogenic DNMT1 expression in breast cancer cells, Gene (online July 11, 2023), Publisher: Elsevier

  2. Yadav P#, Makwana S#, Bansal S#, Soni S,  Mahapatra MK,  Bandyopadhayaya S, Tailor R,  Shrivastava SK,  Sharma LK and  Mandal CC*, Metformin prevents osteoblast-like potenital and calcification in lung cancer A549 cells, Journal of biochemical and molecular toxicology (accepted June 27, 2023), Publisher: Wiley

  3. Soni S, Yadav P and Mandal CC*, Metformin ameliorates BMP2 induced adipocyte-like property in breast cancer cells, Biochemical and Biophysical Research Communications (BBRC) (accepted Jun 14, 2023), Publisher: Elsevier

  4.  Bandyopadhayaya S, Yadav P, Dey S, Sharma A, Nag A, Maheshwari R, Ford BM and Mandal CC*, Oncogenic role of an uncharacterized cold-induced zinc finger protein 726 in breast cancer, Journal of Cellualr Biochemistry (Accepted April 18, 2023), Publisher: Wiley
  5. Seema Kuldeep, Sneha Soni, Anubhav Srivastava, Anjali Mishra, Lokendra Kumar Sharma and Chandi C Mandal*, Dysregulated cholesterol regulatory genes as a diagnostic biomarker for cancer, Journal of Gene Medicine (accepted Jan 12, 2023), Publisher: Wiley
  6. Anmol Kapoor and Chandi C Mandal*, A perspective on bone morphogenetic proteins: Dilemma behind cancer related responses, Current Drug Targets (Accepted Jan 5, 2023), Publisher: Bentham Science
  7. Tencerova, M. and Mandal, C.C*., 2022. Editorial: Bone cell differentiation in health and disease. Front Endocrinol (Lausanne) 13, 1115444.
  8. Mandal, C.C*. and Rhoades Sterling, J.A., 2022. Editorial: Cancer and bone metastasis, volume II.Front Endocrinol (Lausanne) 13, 971240.
  9. Sharma T, Kapoor A. Mandal CC* Duality of bone morphogenetic proteins in cancer: A comprehensive analysis. J Cell Physiol. 2022 May 29, doi:10.1002/jcp.30785,  PMID: 35644005, . Publisher: Wiley
  10. Tripathi V, Bundel R,  Mandal CC* Effect of environmental factors on SARS-CoV-2 infectivity in northern hemisphere countries: A Two-Year Data analysis. Public Health.2022, July; 208:105-110. https://doi.org/10.1016/j.puhe.2022.04.011 Publisher: Elsevier
  11. Mandal CC*, Panwar MS, Yadav CP, Tripathi V, Bandyopadhayaya S. Combinatorial influence of environmental temperature, obesity and cholesterol on SARS-CoV-2 infectivity. Sci Rep. 2022 Mar 21;12(1):4796. doi: 10.1038/s41598-022-08485-6. PMID: 35314722; PMCID: PMC8935894. Publisher: Nature publishing group
  12. Chattopadhyay I, Gundamaraju R, Jha NK, Gupta PK, Dey A, Mandal CC*, Ford BM. Interplay between Dysbiosis of Gut Microbiome, Lipid Metabolism, and Tumorigenesis: Can Gut Dysbiosis Stand as a Prognostic Marker in Cancer? Dis Markers. 2022 Feb 8;2022:2941248. doi: 10.1155/2022/2941248. PMID: 35178126; PMCID: PMC8847007. Publisher: Hindwai
  13. Mandal CC*, Editorial: The Novel Use of Lipids as Diagnostic Tools and Therapeutics in Cancer: Recent Insights and Challenges, Current Drug Targets, 2022;23(6):542-543.  PMID: 35570340, doi: 10.2174/138945012306220425130109, Publisher: Bentham Science
  14. Kumar N, Mandal CC*. Cholesterol-Lowering Drugs on Akt Signaling for Prevention of Tumorigenesis. Front Genet. 2021 Sep 16;12:724149. doi:
    10.3389/fgene.2021.724149. PMID: 34603386; PMCID: PMC8483559. Publisher: Frontiers
  15. Soni S, Torvund M, Mandal CC* Omega-3 fatty acid treatment combined with chemotherapy to prevent toxicity, drug resistance, and metastasis in cancer. Curr Drug Targets. 2021 Sep 1. doi: 10.2174/1389450122666210901121935. Epub ahead of print. PMID: 34488585. Publisher: Bentham Science
  16. Yadav P, Bandyopadhayaya S, Ford BM, Mandal CC*. Interplay between DNA Methyltransferase 1 and microRNAs During Tumorigenesis. Curr Drug Targets. 2021;22(10):1129-1148. doi: 10.2174/1389450122666210120141546. PMID: 33494674. Publisher: Bentham Science
  17. Priyanshi R, Shrama A, Mandal CC*,  Molecular Insights into Phytochemicals-Driven Break Functioned in Tumor Microenvironment, Journal of Food Biochemistry 2021 Sep;45(9):e13824..Publisher: Wiley
  18. Soni S, Torvund M and Mandal CC*, Molecular insights into the interplay between adiposity, breast cancer and bone metastasis, Clin Exp Metastasis. 2021 Apr;38(2):119-138. Publisher: Springer    
  19. Shekhawat RS and Mandal CC*, Anti-obesity Medications in Cancer Therapy: A Comprehensive Insight, Current Cancer Drug Targets, 2021;21(6):476-494. Publisher: Bentham Science
  20. Bandyopadhayaya S, Akimov MG, Verma R, Sharma  A,  Sharma D,  Kundu GC, Gretskaya NM, Bezuglov VV, and Mandal CC*, N-arachidonoyl dopamine inhibits epithelial-mesenchymal transition of breast cancer cells through ERK signaling and decreasing the cellular cholesterol, Journal of Biochemical and Molecular Toxicology [Accepted Dec 12, 2020], Publisher: Wiley
  21.  Pooja, Bandyopadhayaya S, Ford BM, and Mandal CC*, Interplay between DNA methyltransferase 1 and microRNAs during tumorigenesis, Current Drug targets, [Accepted Oct 28, 2020], Publisher: Bentham Science
  22. Mandal CC*. Osteolytic metastasis in breast cancer: effective prevention strategies. Expert  Review of Anticancer Therapy. 2020 Sep;20(9):797-811, Publisher: Taylor & Francis
  23.  Akimov MG, Dudina PV, Gamisonia AM, Gretskaya NM, Zinchenko GN, Mandal CC, Bezuglov VV, the Influence of the Cholesterol Level in Cells on Endovanilloid  Cytotoxicity. Dokl Biochem Biophys. 2020 Jul;493(1):167-170, Publisher: Springer
  24.  Bandyopadhayaya Bundel R, Tyagi S, Pandey A, and Mandal CC*, Can the Aging Influence Cold Environment Mediated Cancer Risk in the USA Female Population?, Journal of Thermal Biology, 2020 Aug;92:102676, Publisher: Elsevier
  25.  Jain S , Bhar K, Bandyopadhayaya S, Kumar S , Mandal CC, Tapryal S, Sharma AK, Development, Evaluation and Effect of Anionic Co-ligand on the Biological Activity of Benzothiazole Derived Copper(II) Complexes, Journal of Inorganic Biochemistry, 2020 Sep;210:111174., Publisher: Elsevier
  26.  Sharma T and Mandal CC*, Omega-3 Fatty Acids in Pathological Calcification and Bone Health, Journal of Food Biochemistry, 2020, June 17, Publisher: Wiley
  27.  Sharma T, Radosevich JA and Mandal CC*, Dual Role of microRNAs in Autophagy of Colorectal Cancer, Endocrine, Metabolic & Immune Disorders - Drug Targets, 2020, May 18, Publisher: Bentham Science
  28.  Mandal CC* and Panwar MS, Can the Summer Temperatures Reduce COVID-19 Cases? Public Health, 2020, June 7, Publisher: Elsevier
  29.  Bandyopadhayaya S, Ford BM and Mandal CC*, Cold-hearted: A case for cold stress in cancer risk, Journal of Thermal Biology 2020, May 16, Publisher: Elsevier
  30.  Jain S, Bhar K, Kumar S, Bandyopadhayaya S, Tapryal S, Mandal CC and Shrama A  Homo- And Heteroleptic Trimethoxy terpyridine-Cu(ii) Complexes: Synthesis, Characterization, DNA/BSA Binding, DNA Cleavage and Cytotoxicity Studies,  Dalton Transactions 2020, March 6. Publisher: Royal Society
  31.  Mandal CC* Editorial: Cancer and bone metastasis, Frontiers in Endocrinology-Bone research, 2019, December 4, Publisher: Frontiers
  32.  Sharma T,  Sharma A, Maheshwari R, Pachori G, Kumari P and  Mandal CC* Docosahexaenoic  acid (DHA) inhibits BMP-2 elevated osteoblast potential of metastatic breast cancer cells (MDA-MB-231) in mammary microcalcification, Nutrition and Cancer 2019,  August 14, Publisher: Taylor and Francis
  33.  Sharma T,  Bandyopadhayaya S, Dhakar R and  Mandal CC* Bone morphogenetic protein 2 increasing epithelial to mesenchymal transition in breast cancer cells with pausing of its proliferation, Research Journal of Biotechnology, 2020, April, 15(4), 136-144
  34.   Neelam DK, Agrawal A, Tomer AK, Bandyopadhayaya S, Sharma A, Jagannadham MV, Mandal CC and Dadheech PK, A Piscibacillus sp. Isolated from A Soda Lake Exhibits Anticancer Activity Against Breast Cancer MDA-MB-231 Cells, Microorganisms 2019 Jan 26;7(2), Publisher: MDPI
  35.   Sharma A, Bandyopadhayaya S, Chowdhury K, Sharma T, Maheshwari R, Kumar V, and  Mandal CC* Metformin exhibited anticancer activity by lowering cellular cholesterol content in breast cancer cells.  PLOS ONE 2019 Jan 9;14(1):e0209435
  36.   Chowdhury K, Sharma A, Kumar S, Gunjan GK, Nag A and Mandal CC* (2017), Colocynth Extracts Prevent Epithelial to Mesenchymal Transition and Stemness of Breast Cancer Cells Frontiers in Pharmacology, 2017 Sep 5;8:593. Publisher: Frontier
  37.   Chowdhury K, Kumar S, Sharma T, Sharma A, Bhagat B, Ford BM, Asthana S and Mandal CC* (2018), Presence of a consensus DNA motif at nearby DNA sequence of the mutation susceptible CG nucleotides, Gene,  2018 Jan 10;639:85-95 [Oct 3, 2017 E-pub ahead] Publisher: Elsevier
  38.   Sharma A, Sharma T, Panwar MS, Sharma D, Bundel R, Hamilton RT, Radosevich JA, and Mandal CC* (2017) Colder environments are associated with a greater cancer incidence in the female population of the United States, Tumor Biology, 2017, oct;39(10):1010428317724784 (12th Oct, 2017, E-pub ahead). Publisher: SAGE
  39.    Chowdhury K, Sharma A, Sharma T, Kumar S, and Mandal CC* (2017), Simvastatin and MBCD Inhibit Breast Cancer Induced Osteoclast Activity by Targeting Osteoclastogenic Factors, Cancer Investigation, Jul 3;35(6):403-413, 2017. Publisher: Taylor & Francis
  40.   Mandal CC*, Sharma A, Panwar MS and Radosevich JA, Is Cholesterol a mediator of Coldinduced cancer? (2016), Tumor Biology, 2016 Jul;37(7):9635-48, Publisher: Springer
  41.   Gayan S, Mandal CC, and Sen SK, Expression of an engineered synthetic cry2Aa (D42/K63F/K64P) gene of Bacillus thuringiensis in marker free transgenic tobacco facilitated full-protection from cotton leaf worm ( S. littoralis) at very low concentration (2016) World Journal of Microbiology and Biotechnology, 2016 Apr;32(4):62,  Publisher: Springer
  42.   Sharma T, Pachoori G, Radosevich JA, and Mandal CC*, A Molecular View of Pathological Microcalcification in Breast Cancer (2016), Journal of Mammary Gland   Biology and Neoplasia, 2016 Jun;21(1-2):25-40. doi: 10.1007/s10911-015-9349-9, Publisher: Springer
  43.   Pandey RK, Prajapati P, Sharma T, Mandal CC and Prajapati VK, Epidemiological Investigation of a Jaundice outbreak in Kishangarh, Rajasthan, India, 2014 (2016), Journal of Public Health, 2016 Apr,24 (2): 83-89. Publisher: Springer
  44.   Mandal CC, Das F, Ganapathy S, Harris SE, Ghosh Choudhury G, Ghosh-Choudhury N, BMP-2 Activates NFATc1 via an Autoregulatory Loop Involving Smad/Akt/Ca2+ Signaling (2016). Journal of Biological Chemistry, Jan 15;291(3):1148-61, Publisher: American society for Biochemistry and Molecular Biology
  45.   Mandal CC, High cholesterol deteriorates bone health: new insights into molecular mechanisms (2015), Frontiers in Endocrinology, Oct 23;6:165, Publisher: Frontier Media SA
  46.   Gayen S, Samanta MK, Hossain MA, Mandal CC and Sen SK, A deletion mutant ndv200 of the Bacillus thuringiensis vip3BR insecticidal toxin gene is a prospective candidate for the next generation of genetically modified crop plants resistant to lepidopteran insect damage  (2015), Planta, July;242(1):269-81. Publisher: Springer
  47.   Kumar S, Nag A and Mandal CC*, A Comprehensive Review on miR-200c, a Promising  Cancer Biomarker with Therapeutic Potential (2015), Current Drug Targets, 16(12):1381- 403 Publisher: Bentham Science
  48.   Mehta J, Asthana S, Mandal CC and Saxena S, A molecular analysis provides novel insights into androgen receptor signalling in breast cancer (2015), Plos One, 10(3):e0120622 Publisher: Public Library of Science
  49.   Sharma A, Verma HK, Joshi S, Panwar MS and Mandal CC*, A link between cold environment and cancer (2015), Tumor Biology, 36(8):5953-64, Publisher: Springer
  50.   Mandal CC* and Rahman MM, An Update of Bone Morphogenetic Proteins as Biomarker and Therapy for Cancer (2015), Journal of Carcinogenesis and Mutagenesis, 6:e113
  51.   Sharma T, Hamilton R and Mandal CC*, miR-214: a potential biomarker and therapeutic for different cancers (2015), Future Oncology, 11(2):349-63. Publisher: Future Science Group
  52.   Mandal CC* and Rahman MM, Targeting Intracellular Cholesterol is a Novel Therapeutic Strategy for Cancer Treatment (2014), Journal of Cancer Science and Therapy, 6(12):510- 513.
  53.   Urbańska K and Mandal CC*, Advanced Views of Glioblastoma Multiforme U-87 Cells for Therapy of Brain Tumor (2014), International Journal of Clinical Biochemistry and Research, (1):59-66. Publisher: Innovative publication 
  54.   Dandapat A, Bhattacharyya J, Gayen S, Chakraborty A, Banga A, Mukherjje R, Mandal CC, Hossain MA, Roy S Basu A and Sen SK, Variant Cry1Ab entomocidal Bacillus thuringiensis toxin gene facilitates the recovery of an increased number of lepidopteran insect resistant independent rice transformants against yellow stem borer (Scirpophaga incertulus) inflicted damage (2014), Journal of Plant Biochemistry and Biotechnology, 23(1):81-92 Publisher: Springer
  55.   Ghosh-Choudhury N, Mandal CC, Das F, Ahuja S, Ghosh-Choudhury G, c-Abl-dependent molecular circuitry involving smad 5 and phosphatidylinositol 3 kinase regulates bone morpohogenetic protein-2-induced osteogenesis (2013), Journal of Biological Chemistry, Aug 23;288(34):24503-17. Publisher: American society for Biochemistry and Molecular Biology
  56.   Mandal CC, Ghosh-Choudhury T, Dey N, Ghosh-Choudhury G and Ghosh-Choudhury N. miR-21 is targeted by Omega-3 Polyunsaturated Fatty Acids to regulate breast tumor CSF-1 expression (2012), Carcinogenesis , Oct;33(10):1897-908 Publisher: Oxford University Press
  57.   Dey N, Das F, Ghosh-Choudhury N, Mandal CC, Parekh DJ, Block K, Kasinath BS, Abboud HE and Ghosh Choudhury G (2012) microRNA-21 governs TORC1 activation in renal cancer cell proliferation and invasion, PLoS ONE, 7(6):e37366. Publisher: Public Library of Science
  58.   Das F, Ghosh-Choudhury N, Dey N, Mandal CC, Mahimainathan L, Kasinath BS, , Abboud HE and Ghosh Choudhury G (2012) Unrestrained Mammalian Target of Rapamycin Complexes 1 and 2 Increase Expression of Phosphatase and Tensin Homolog Deleted On Chromosome 10 to Regulate Phosphorylation of Akt, Journal of Biological Chemistry, Feb  3;287(6):3808-22. Publisher: American society for Biochemistry and Molecular Biology
  59.   Dey N, Das F, Mariappan MM, Mandal CC, Ghosh-Choudhury N, Kasinath BS and Ghosh Choudhury G (2011), microRNA-21 orchestrates high glucose-induced signals to TORC1 for renal cell pathology in diabetes, Journal of Biological Chemistry, July 22;286(29):25586- 603. Publisher: American society for Biochemistry and Molecular Biology
  60.   Mandal CC, Ghosh-Choudhury N, Yoneda T, Ghosh-Choudhury G and Ghosh-Choudhury N (2011). Simvastatin prevents skeletal metastasis of breast cancer by an antagonistic interplay between p53 and CD44, Journal of Biological Chemistry, April 286(13):11314- 11327. Publisher: American society for Biochemistry and Molecular Biology
  61.   Mandal CC, Ganapathy S, Gorin YC, Mahadev K, Block K, Abboud H, Harris SE, GhoshChoudhury G and Ghosh-Choudhury N (2011). Reactive oxygen species derived from NOX- 4 mediate BMP-2 gene transcription and osteoblast differentiation, Biochemical Journal, Jan 15;433(2):393-402. Publisher: Portland Press Ltd on behalf of the Biochemical Society
  62.   Mandal CC, Ghosh-Choudhury T, Yoneda T, Ghosh-Choudhury G and Ghosh-Choudhury N (2010). Fish oil prevents breast cancer cell metastasis to bone, Biochemical and   Biophysical Research Communications, Nov;402(4):602-607. Publisher: Elsevier
  63.   Mandal CC, Drissi H, Ghosh-Choudhury G and Ghosh-Choudhury N (2010). Integration of Phosphatidylinositol 3-kinase, Akt kinase and Smad signaling pathway in BMP-2-induced Osterix expression, Calcified Tissue International, Dec;87(6):533-40. Publisher: Springer
  64.   Ghosh-Choudhury N*, Mandal CC*, Ghosh-Choudhury G and Ghosh-Choudhury N (2010). Simvastatin induces derepression of PTEN expression via NFkappa B to inhibit breast cancer cell growth, Cellular Signaling, May;22(5):749-58 (*Equal contribution). Publisher: Elsevier
  65.   Mandal CC, Ghosh-Choudhury G and Ghosh-Choudhury N (2009). Phosphatidylinositol 3- kinase/Akt signal relay cooperates with smad in bone morphogenetic protein-2-induced colony stimulating factor-1 (CSF-1) expression and osteoclast differentiation, Endocrinology, Nov;150(11):4989-98. Publisher: Endocrine Society USA
  66.   Mahimainathan L, Ghosh-Choudhury N, Venkatesan B, Das F, Mandal CC, Dey N, Habib SL, Kasinath BS, Abboud HE and Ghosh Choudhury G (2009). TSC2 deficiency increases  PTEN via HIF1alpha, Journal of Biological Chemistry, Oct;284(41):27790-8. Publisher: American society for Biochemistry and Molecular Biology
  67.   Ghosh-Choudhury T, Mandal CC, Woodruff K, St Clair P, Fernandes G, Choudhury GG and Ghosh-Choudhury N (2009). Fish oil targets PTEN to regulate NFkappaB for downregulation of anti-apoptotic genes in breast tumor growth, Breast Cancer Research and Treatment, Nov;118(1):213-28. Publisher: Springer  
  68.   Mandal CC, Gayen S, Basu A, Ghosh KS, Dasgupta S, Maiti MK, and Sen SK (2007). Prediction-based protein engineering of domain I of Cry2A entomocidal toxin of Bacillus thuringiensis for the enhancement of toxicity against lepidopteran insects, Protein Engineering Design and Selection, Dec;20(12):599-606. Publisher: Oxford University Press
  69.   Ghosh-Choudhury N, Mandal CC and Choudhury GG (2007). Statin-induced Ras activation integrates the phosphatidylinositol 3-kinase signal to Akt and MAPK for bone morphogenetic protein-2 expression in osteoblast differentiation, Journal of Biological Chemistry, Feb;282(7):4983-93. Publisher: American society for Biochemistry and Molecular Biology
  70.   Saha T, Ghose PB, Mandal CC and Bandyopadhya TS (2003). Waste water qualitystatus of the Tally nulla in Calcutta, Indian Journal of Environmental Health, July;45(3):221-6. Publisher: NEERI, India, ISSN: 0367-827X,  
  71.   Saha T, Ghosh PB, Mandal CC and Bandyopadhyay TS (2001). Quality Assessment of Bagjola Canal Waste Water, Calcutta, Journal of Inland Fisheries Society of India, Dec;32(2):76-80. Publisher: Inland Fisheries Society of India, ISSN: 0379-3435 
  72.   Saha T, Ghosh PB, Mandal CC and Bandyopadhyay TS (2000). Water Quality Monitoring of Beliaghata-Kestopur Canal of Calcutta, Journal of The Institution of Public Health Engineers, India, 2000(4):53-58. Publisher: Institution of Public Health Engineers, India, ISSN: 0970-3195 

 

 

Book Chapters:

  1. Nunia V, Quershi S, Mahapatra MK and Mandal CC, Therapeutic approaches of phospholipase C inhibitors in breast cancer, Elsevier (accepted June 1, 2023)
  2. Makwana S and Mandal CC, Animal models for angiogenesis on cancer research, Springer (accepted March 11, 2022)
  3. Mahapatra MK and Mandal CC, Animal models for bone metastasis stud,y Springer (accepted March 11, 2022)
  4. Yadav P and Mandal CC,   Usefulness of bioimaging in modern day research, Springer (accepted Februrary 9, 2022)
  5. Makwana S and Mandal CC, Interplay between miRNAs and Reactive Oxygen Species in Cancer Stem Cells: New Perspective in Cancer Metastasis,  Handbook of Oxidative Stress in Cancer: Therapeutic Aspects,  ISBN: 978-981-16-1247-3 Springer, Dec, 2021
  6. .Mahapatra MK, MS and Mandal CC, Natural Extracts Target NF-κB and Reactive Oxygen Species: Molecular Insights into Therapy Resistance and Toxicity, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects,  ISBN: 978-981-16-1247-3, Springer, 2022
  7. Soni S, Bandyopadhayaya S  and Mandal CC, Animal Models Systems of Cancer for Preclinical Trials, Pharmacotherapeutic Botanicals for Cancer Chemoprevention, ISBN: 978-981-15-5998-3, Springer, 2020
  8.   Shrama A, Priyanshi  and Mandal CC, Modulation of Cancer Cell Metabolism and Microenvironment by Phytochemicals, Pharmacotherapeutic Botanicals for Cancer Chemoprevention, ISBN: 978-981-15-5998-3, Springer, 2020
  9.   Vijayvergia U, Bandyopadhayaya S  and Mandal CC, Biphasic Effects of Phytochemicals and their Relevance to Cancer Therapeutics, Pharmacotherapeutic Botanicals for Cancer Chemoprevention, ISBN: 978-981-15-5998-3, Springer, 2020
  10.   Sharma T and Mandal CC, Technological Advancement in Cancer Stem Cell Research, Cancer Stem Cells: New Horizons in Cancer Therapies, ISBN: 978-981-15-5119-2, Springer, 2020
  11.   Bandyopadhayaya S and Mandal CC, A Differential Role of miRNAs in Regulation of Breast Cancer Stem Cells, Cancer Stem Cells: New Horizons in Cancer Therapies, ISBN: 978-981-15-5119-2, Springer, 2020
  12.   Bandyopadhayaya S and Mandal CC, Blood-Based Biomarkers for the Diagnosis and Prognosis of Cancer, Precision Medicine in Oncology (Editor: James A. Radosevich), ISBN: 9781119432449, Wiley Blackwell, 2020
  13.   Mandal CC, Mehta J and Prajapati V. (2018) Programmed death 1 (PD1) mediated T cell apoptosis and cancer immune therapy, Apoptosis and Beyond: The Many  Ways Cells Die (Editor: James A. Radosevich),  WILLEY blackwell, ISBN:1119432421
  14.   Mehta J and Mandal CC. (2018) Cyclophilin D-dependent Necrosis, Apoptosis and Beyond: The Many  Ways Cells Die (Editor: James A. Radosevich), WILLEY blackwell, ISBN:1119432421  
  15.   Bhattacharyya J, Mukherjee R, Banga A, Dandapat A, Mandal CC, Hossain MA, Banerjee N, Ghosh AK, Choudhury AH, Mandol A,  Maiti MK, Basu A, Ghosh D, Das S, Basu D, Mishra S, Nayak P and Sen SK (2007). A transgenic approach for developing insect resistant rice plant types, 245-264, Science, technology and trade for peace and prosperity (P.K. Aggarwal, J.K. Ladha, R.K. Singh, C. Devakumar, B. Hardy), MacMillan India Ltd. 
  16.   Bhattacharyya J, Banga A, Mukherjee R, Vedula J, Hossain MA, Sen S, Mandal CC, Choudhury AH, Dandapat A, Biswas P, Basu A, Maiti MK, Ghosh D, Basu D, Das S, Nayak P and Sen SK (2004). Continuing the golden harvest: Development of insect resistant transgenic rice, 239-254, Biotechnology for a better future (L. D’Souza), SAC publication, Mangalore, India 
  17.   Saha T, Ghose PB, Mandal CC and Bandyopadhaya TS (2003). Ecology of some canals of kolkata in relation to bacterial population, 185-191, chapter 18, Aquatic Ecosystem (Kul Bhushan Nangia). A.P.H. Publishing Corporation, New Delhi, ISBN: 81-7648-454-7  

 ​Research Project:

  • Deciphering the influence of adipocyte-like cell subpopulation transdifferentiated from breast cancer cells in tumorigenic activity and its therapeutic potential (ICMR) [Ref. 2021/9936]  [PI]

  • Conjugated approach for more effective Cu and Ru Metal Based Molecular Agents with Enhanced Anti-Cancer Potential and Reduced Side-Effects (DST-SERB) [Ref. SERB/F/7709/2022-2023] [Co-PI]

  • Exploring the impact of an osteoblast-like cell subpopulation differentiated from breast cancer cells on tumorigenic activity and its possible therapeutic potential (DST-SERB)  [Ref. CRG/2021/002963][PI]
  • Exploring the role of  secretary arm of autophasy in glioblastoma therapy resistance in invitro and patient data based study (ICMR) [Ref. 52/27/2020-BIO/BMS] [Co-PI]
  • Interplay of metabolic and signal pathways of N-acyl dopamines and cholesterol in cancer cells (DST-RFBR) [Ref. INT/RUS/RFBR/P-256](Indo-Russia) [PI]
  • Cholesterol-lowering drug targets osteoclastogenic factors to prevent osteolytic bone metastasis of breast cancer (DBT) [Ref. 6242-P9/RGCB/PMD/DBT/CCML/2015] [PI]
  • Rationally designed Indolizine derivative(s) as multitarget anticancer agent for inhibition of cancer cell growth and metastasis (DST-SERB) [Ref. EMR/2014/000928] [Co-PI]
  • Influence of diabetes on bone metastasis of breast cancers (UGC-BSR Start-up grant) [PI]

Attended

Presentations in Conferences/ Symposiums:

  1. Mandal CC, An unexplored zinc finger protein bridges the relationship between cold temperature and cholesterol in breast cancer” on 30th January 2023, Snippets of Life Sciences Research in India: Honoring Prof. Debi P. Sarkar, Department of Biochemistry, University of Delhi-South Campus [Invited Speaker]
  2. Mandal CC, Tumorigenic potentiality of an unfamiliar cold-induced zinc finger protein in cancer and its prevention strategy, 16th international cancer symposium of translational chemoprevention and brain storming, Nov 18-19, 2022, JNU, New Delhi, India [Invited Speaker]
  3. Mandal CC, A new drug targets dysregulated cholesterol metabolism for prevention of cancer growth and metastasis, 5th International Conference on Nutraceuticals and Chronic Diseases (INCD2022 from October 7-9, 2022 University of Delhi, India.[Invited Speaker]
  4. Mandal CC, Omega-3 Fatty Acid Inhibited Microcalcification by Targeting Osteoblast Potential of Breast Cancer Cells 13th International Symposium on “Cancer Prevention and Treatment”, 2020, JNU, New Delhi (Invited Speaker)
  5. Mandal CC, Targeting osteoblast-like potential in cancer cells, 8th International Translational Cancer Research Conference, 2020, BHU, Varanasi, India (Invited Speaker)
  6. Mandal CC, Anti-diabetic metformin suppressed BMP-2 induced osteoblast-like potential in lung cancer cells, National Symposium on Basic & Translational Research in Cancer Biology 2019, Institute of Advanced Research, Gujarat (Invited speaker)
  7. Mandal CC, Cholesterol Lowering Simvastatin Targets NFATc1-DKK1-CSF1 Axis toInhibit Breast Cancer Induced Osteoclast Activity in the international symposium on Tumor Microenvironment and Cancer Prevention & Therapeutics 2019, JNU, New Delhi, India (Invited Speaker)
  8.   Mandal CC, Targeting cellular cholesterol prevents cancer, International Conference on International Conference on LSRIEAS-2018, BITS-Pilani, India (Invited speaker)
  9.   Mandal CC, An Intriguing link between cholesterol and tumorigenesis, Institute of Bioorganic Chemistry, Russia, Moscow (Invited Lecture)--2018
  10.   Mandal CC, Omega-3 Fatty Acid Disrupts BMP Signaling to Prevent Micro calcification in  Breast Cancer, 7th International Conference on Translational Cancer Research, ICTCR 2018, Chennai, Inida (Invited speaker)
  11.   Mandal CC, Cold temperature: a not-estimated cancer risk factor, NSCPTS 2017 (Plenary speaker) 
  12.   Mandal CC Influence of cold temperature and cellular cholesterol on breast cancer growth and metastasis, RGCON 2017, New Delhi, India (Invited Faculty) 
  13.   Mandal CC, Cholesterol Depleting Methyl-β-cyclodexytrin Prevents Epithelial to Mesenchymal Transition and Breast Cancer Driven Osteoclast Activity (2017), 3rd international conference on Perspective of Cell Signaling and Molecular Medicine, Bose Institute, Kolkata, India. (Invited Speaker) 
  14.   Mandal CC* (2016) Influence of Cellular Cholesterol on Breast Cancer Induced Bone Metastasis,  ICSCC-2016, Ravindra Bhavan, Margao, Goa, India.  (Invited Speaker) 
  15.   Mandal CC*, Sharma A, Panwar M (2016), Is there a tie between risk factors cold environment and cholesterol in cancer? International Conference Indian Association for Cancer research (IACR), New Delhi, India (Invited Speaker) 
  16.   Mandal CC*, Sharma A, Ghosh-Choudhury (2016), An intriguing link between cholesterol and cancer, International Conference BCGGR, BITS-PILANI, India (Keynote Speaker) 
  17.   Mandal CC*, Sharma T, Sharma A, Ghosh-Choudhury N (2016), Fish Oil and Cholesterollowering Drug Prevent Breast Cancer Growth and Metastasis, International Symposium on Role of herbals in Cancer prevention and treatment, Jawaharlal Nehru University, New Delhi, India (Oral Presentation) 
  18.   Mandal CC* (2015), Cold Environmental Temperature May Enhance Cancer Risk by Augmenting Cholesterol, Global Cancer Summit 2015, Bangalore, India. (Invited speaker). 
  19.   Mandal CC* (2015) Combinatorial Treatment with Cholesterol-lowering Drug and Omega3 fatty Acid Prevents Breast Cancer Growth, Current Challenges in Drug Discovery Research, MNIT, Jaipur, India. (Invited speaker). 
  20.   Mandal CC* (2014), A Cholesterol Lowering Drug Prevents Osteolytic Bone Metastasis by Targeting Osteoclastogenic Factors in Bone Microenvironment, 9th International Conference on Anticancer Research, Sithonia, Greece [Invited Speaker]. 
  21.   Mandal CC* (2014), Omega-3 fatty acids prevent breast cancer bone metastasis and side effects of chemotherapies, Global Cancer Conference, Hyderabad, India [Plenary Speaker] 
  22.   Mandal CC*, Ghosh-Choudhury G and Ghosh-Choudhury N (2013) Simvastatin inhibits Osteoclastogenic Factors to block Osteolytic Bone Metastasis of Breast Cancer, 4th International Conference on Stem Cells and Cancer, Bombay, India [Oral presentation] 
  23.   Sharma T, Parihar N , Nath S, Singh A, Kaur S, Singh S, and Mandal CC* (2013) A Nontoxic Approach to Prevent Secondary Effects of Chemotherapies, Bioquest 2013, Elsevier, Kerala, India. [Oral Presentation] 
  24.   Mandal CC*, Ghosh-Choudhury G and Ghosh-Choudhury N (2012). Cholesterol-lowering  Drug Targets Osteoclastogenic Factors to Prevent Osteolytic Bone Metastasis of Breast Cancer,3rd   International Cancer Research Symposium, Journal of Cell Communication and Signaling, Kolkata, India. [Invited Speaker] 
  25.   Mandal CC, Tamegnon A, Ghosh-Choudhury T, Ghosh-Choudhury G and GhoshChoudhury N (2012). Omega 3 Fatty Acids in Fish Oil Orchestrate a Reciprocal Axis between p53-miR200c and Zeb1 to Prevent EMT in Breast Cancer Cells, 34th Annual Meeting of the American Society for Bone and Mineral Research, JBMR, Minneapolis, Minnosota, USA. 
  26.   Mandal CC, Ghosh-Choudhury T, Ghosh-Choudhury G and Ghosh-Choudhury N (2011). Fish oil targets miR-21 to increase PTEN expression for inhibition of bone metastatic CSF-1 in breast cancer cells, Program # P2-01-11, 34th Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA.  [Broadcast in KENS5 San Antonio, KVUE Austin, and CBS  National TV Channel] 
  27.   Mandal CC, Ghosh-Choudhury G, Ghosh-Choudhury T and Ghosh-Choudhury N (2011). Omega3 fatty acids orchestrate an antagonistic interplay of microRNA expression to prevent epithelial to mesenchymal transdifferentiation of breast cancer cells, Abs# 31, 4th Annual Symposium of Cancer Therapy & Research Center (CTRC), San Antonio, Texas, USA. 
  28.   Mandal CC, Ghosh-Choudhury T, Ghosh-Choudhury G and Ghosh-Choudhury N (2011). A Non-invasive Way to Target microRNA-21 and to Prevent Osteometastatic CSF-1 Expression by the Human Breast Cancer Cells via PTEN, Abs# 113, 33rd Annual Meeting of the American Society for Bone and Mineral Research, JBMR, San Diego , USA. 
  29.   Dey N, Ghosh-Choudhury N, Das F, Mariappan MM, Mandal CC, Kasinath BS  and Ghosh Choudhury G (2010). Micro RNA-21(miR-21) targets PTEN to regulate mesangial cell hypertrophy and fibronectin expression by high glucose, Abs# TH-FC141, 43rd Annual meeting and Scientific Exposition, American Society of Nephrology, Denver, USA. 
  30.   Das F, Ghosh-Choudhury N, Mandal CC, Dey N, Kasinath BS and Ghosh Choudhury G (2010). A feedback loop in high glucose-induced inactivation of FoxO1 regulates Akt activation, mesangial cell hypertrophy and fibronectin expression via downregulation of catalase, Abs# F-PO1113, 43rd Annual meeting and Scientific Exposition, American Society of Nephrology, Denver, USA. 
  31.   Mandal CC, Ghosh-Choudhury N, Yoneda T, Ghosh-Choudhury G and Ghosh-Choudhury N (2010). Simvastatin prevents breast cancer skeletal metastasis by increasing p53 levels to increase PTEN and inhibit CD44 expression, Program # P2-07-01, 33rd Annual San Antonio Breast Cancer Symposium, San Antonio, Texas, USA. [University of Texas Health Science Center News (24th Nov, 2010) and San Antonio Express News (2nd Dec, 2010)] 
  32.   Mandal CC, Ghosh-Choudhury N, Yoneda T Ghosh-Choudhury G and Ghosh-Choudhury N (2010). Unveiling dual functions of p53 in preventing breast cancer bone metastasis by targeting CD44 and PTEN, Abs# 1230, 32nd Annual Meeting of the American Society for Bone and Mineral Research, JBMR, Toronto, Canada.  [Young Investigator Travel Grant Recipient and Oral Presentation] 
  33.   Borgfeld N, Mandal CC and Ghosh-Choudhury N (2010). The reduction of colony  stimulating factor-1 (CSF-1) expression in MDA-MB-231 by Omega-3 fatty acids, Cancer Research Summer Program, UTHSCSA, San Antonio, Texas, USA. 
  34.   Mandal CC, Ghosh-Choudhury G, Yoneda T and Ghosh-Choudhury N (2009). Omega-3 fatty acids (OFAs) intercept miR-21 and miR-214 targeting PTEN to prevent breast cancer bone metastasis, Abs# SU0113, 31st Annual Meeting of the American Society for Bone and Mineral Research, JBMR, Denver, USA. [Medical Tribune, Congress News Wave, Japan]  
  35.   Mandal CC, Ganapathy S, Ghosh-Choudhury G and Ghosh-Choudhury N (2009). BMP-2- stimulated NOX4-PI3 kinase-Akt signaling axis induces osteoblast (OB) differentiation, Abs# MO0184, 31st Annual Meeting of the American Society for Bone and Mineral Research, JBMR, Denver, USA. 
  36.   Mandal CC, Ghosh-Choudhury G and Ghosh-Choudhury N (2008). BMP-2 stimulates a feedback activation loop for expression of NFATc1 in osteoblast, Abs# SA02, 30th Annual Meeting of the American Society for Bone and Mineral Research, JBMR, Montreal, Canada. [Plenary Poster]  
  37.   Mandal CC, Ghosh-Choudhury G, Ganapathy S, Harris SE and Ghosh- Choudhury N (2008). A BMP-2 stimulated signaling niche in osteoblast comprising Smad and PI3K kinase /Akt regulates NFATc1 expression and its nuclear translocation, Abs# 1081, 30th Annual Meeting of the American Society for Bone and Mineral Research, JBMR, Montreal, Canada. [Young Investigator Award and Oral Presentation]  
  38.   Mandal CC and Ghosh-Choudhury N (2008). Simvastatin induces Wnt signaling and reduces CSF-1 secretion and RANKL/OPG ratio to block osteoclast differentiation, Abs# SU096, 30th Annual Meeting of the American Society for Bone and Mineral Research, JBMR, Montreal, Canada. 
  39.   Mandal CC, Ghosh-Choudhury G, Drissi H and Ghosh-Choudhury N (2007). BMP2Inducible Osterix regulates Bone remodeling by Increasing Osteoblastic CSF-1 and RANKL/ OPG ratio To Induce Osteoclast maturation, Abs# M100, 29th Annual Meeting of the American Society for Bone and Mineral Research, JBMR, Honolulu, Hawaii, USA. 
  40.   Mandal CC, Ghosh-Choudhury G, Drissi H and Ghosh-Choudhury N (2007).   Osteoblastic Master regulator Osterix Mediates the feedback regulation of BMP-2 Auto- Expression via  PI3 kinase/ AKt signaling, Abs# T029, 29th Annual Meeting of the American Society for Bone and Mineral Research, JBMR, Honolulu, Hawaii, USA.  [Travel Award] 
  41.   Bhattacharyya J, Mukherjee R, Banga A, Dandapat A, Mandal CC and Sen SK    (2006). Transgenic approach for development of insect resistant rice plant types. Abs# 5421, 2nd International Rice Congress, New Delhi, India. 
  42.   Mandal CC, Singha PK, Pandeswara SL, Ghosh-Choudhury G and Ghosh Choudhury N (2006). Phosphatidlyinositol (PI) 3 kinase/ Akt Signaling Represents a Potential Mechanism for BMP-2- induced Expression of Colony Stimulating Factor-1(CSF-1) which mediates Osteoclast Differentiation. Abs# F183, 28th   Annual Meeting of the American Society for Bone and Mineral Research, JBMR, Philadelphia, USA.  [Plenary Poster]  
  43.   Singha PK, Mandal CC, Pandeswara SL, Ghosh-Choudhury G and Ghosh-Choudhury N (2006). Phosphatidlyinositol (PI) 3 kinase/ Akt Signal Trafficking    Activates NADP(H) oxidase (NOX) and NFkB in Response to Hydrogen Peroxide (H2O2), which Regulates Osteoblast Differentiation. Abs# SA224, 28th Annual Meeting of the American Society for Bone and Mineral Research, JBMR, Philadelphia, USA. 
  44.   Maiti MK, Nayak P, Basu A, Dandapat A, Mandal CC, Ghosh D, Basu D, Das S and Sen SK (2001). Performance of Bt IR64 rice plants resistant against yellow stem borer in their advance generations, Asian Agriculture Congress, Manila, Philippines. 
  45.   Mandal CC, Ghosh-Choudhury G, Ghosh-Choudhury T and Ghosh-Choudhury N, Omega3 fatty acids orchestrate an antagonistic interplay of microRNA expression to prevent epithelial to mesenchymal transdifferentiation of breast cancer cells (2nd November, 2011), Abs# 31, 4th Annual Symposium of Cancer Therapy & Research Center (CTRC), San Antonio, Texas, USA. 
  46.   Mandal CC, Borgfeld N and Ghosh-Choudhury N, Omega-3 Fatty Acids Targets miR-21 to Differentially Regulate Expressions of the Tumor Suppressor Protein PTEN and the Prometastatic CSF-1 in Human Breast Cancer Cells (8th April, 2011), 3rd Annual Terry Mikiten, Ph.D. Graduate Student Research Forum, UTHSCSA, San Antonio, Texas, USA.  
  47.   Mandal CC, Ghosh-Choudhury T, Ghosh-Choudhury G and Ghosh-Choudhury N, Fish Oil Intercepts CSF-1 Expression by Breast Cancer Cells to block Osteolytic Metastasis (3rdNovember, 2010),. Abs# 3, 3rd Annual Symposium of Cancer Therapy & Research Center (CTRC), San Antonio, Texas, USA, 2010. [2nd Place Winner] 
  48.   Mandal CC, Choudhury GG, Yoneda T and Ghosh-Choudhury N, Omega-3 Fatty Acids Block  miR-21 and miR-214 to Target PTEN Expression and Prevent Breast Cancer Bone Metastasis (5th May, 2010),. 2nd Annual Terry Mikiten, Ph.D. Graduate Student Research Forum, UTHSCSA, San Antonio, Texas, USA 

Organized

Organizing Committee Member,  43rd Annual Meeting of The International Society  Of Oncology and Biomarkers (ISOB), Sept, 2016, Chicago, USA    

Organizing Secretary, International Conference of Molecular Basis of Diseases and Therapeutics (ICMBDT 2019), Central University of Rajasthan, March 8-10, 2019